A detailed history of Alphabet Inc. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 889,979 shares of SPRO stock, worth $1.05 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
889,979
Previous 889,979 -0.0%
Holding current value
$1.05 Million
Previous $1.16 Million 3.11%
% of portfolio
0.08%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 14, 2022

SELL
$11.65 - $22.07 $2.59 Million - $4.91 Million
-222,494 Reduced 20.0%
889,979 $17.3 Million
Q4 2017

Nov 14, 2022

BUY
$10.43 - $14.75 $11.6 Million - $16.4 Million
1,112,473
1,112,473 $13.1 Million

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $41.4M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.